BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26281849)

  • 1. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
    Buchholz HG; Wenzel F; Gartenschläger M; Thiele F; Young S; Reuss S; Schreckenberger M
    Biomed Eng Online; 2015 Aug; 14():79. PubMed ID: 26281849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of
    Presotto L; Ballarini T; Caminiti SP; Bettinardi V; Gianolli L; Perani D
    Neuroinformatics; 2017 Apr; 15(2):151-163. PubMed ID: 28063108
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    Moodley KK; Perani D; Minati L; Della Rosa PA; Pennycook F; Dickson JC; Barnes A; Contarino VE; Michopoulou S; D'Incerti L; Good C; Fallanca F; Vanoli EG; Ell PJ; Chan D
    J Alzheimers Dis; 2015; 46(3):639-53. PubMed ID: 26402512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
    Wenzel F; Young S; Wilke F; Apostolova I; Arlt S; Jahn H; Thiele F; Buchert R
    Neuroimage; 2010 Apr; 50(3):994-1003. PubMed ID: 20053378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT.
    Hosaka K; Ishii K; Sakamoto S; Sadato N; Fukuda H; Kato T; Sugimura K; Senda M; ;
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):92-7. PubMed ID: 15322767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease.
    Buchert R; Wilke F; Chakrabarti B; Martin B; Brenner W; Mester J; Clausen M
    J Neuroimaging; 2005 Oct; 15(4):348-55. PubMed ID: 16254400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of different 18FDG PET healthy subject scans for comparison with single patient in SPM analysis.
    Gallivanone F; Della Rosa PA; Perani D; Gilardi MC; Castiglioni I;
    Q J Nucl Med Mol Imaging; 2017 Mar; 61(1):115-132. PubMed ID: 25479418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.
    Della Rosa PA; Cerami C; Gallivanone F; Prestia A; Caroli A; Castiglioni I; Gilardi MC; Frisoni G; Friston K; Ashburner J; Perani D;
    Neuroinformatics; 2014 Oct; 12(4):575-93. PubMed ID: 24952892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
    Chen WP; Matsunari I; Noda A; Yanase D; Yajima K; Takeda N; Yamada M; Minoshima S; Nishimura S
    J Nucl Med; 2005 Oct; 46(10):1633-41. PubMed ID: 16204713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
    Perani D; Della Rosa PA; Cerami C; Gallivanone F; Fallanca F; Vanoli EG; Panzacchi A; Nobili F; Pappatà S; Marcone A; Garibotto V; Castiglioni I; Magnani G; Cappa SF; Gianolli L;
    Neuroimage Clin; 2014; 6():445-54. PubMed ID: 25389519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
    Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
    Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
    Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
    Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal epilepsy lesions may be detected by the voxel-based quantitative analysis of brain FDG-PET images using an original block-matching normalization software.
    Verger A; Yagdigul Y; Van Der Gucht A; Poussier S; Guedj E; Maillard L; Malandain G; Hossu G; Fay R; Karcher G; Marie PY
    Ann Nucl Med; 2016 May; 30(4):272-8. PubMed ID: 26841946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.
    Wu X; Chen K; Yao L; Ayutyanont N; Langbaum JB; Fleisher A; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Foster NL; Thompson PM; Harvey DJ; Weiner MW; Koeppe RA; Jagust WJ; Reiman EM;
    J Neurosci Methods; 2010 Oct; 192(2):277-85. PubMed ID: 20678521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity normalization methods in brain FDG-PET quantification.
    López-González FJ; Silva-Rodríguez J; Paredes-Pacheco J; Niñerola-Baizán A; Efthimiou N; Martín-Martín C; Moscoso A; Ruibal Á; Roé-Vellvé N; Aguiar P
    Neuroimage; 2020 Nov; 222():117229. PubMed ID: 32771619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.